In line with this, western blot analysis indicated that SW480 CRC-Exo (100 μg/mL) caused a considerable decrease in the protein levels of PHLPP1/2, while the treatment triggered Akt phosphorylation in fibroblasts (Figure 5F(Fig. 5)). The gene discussed is AKT1; the disease is colorectal carcinoma.